TL;DR: Cannabis equities open the July 13 trading week with MSOS holding multi-month gains after last week’s constructive close, as the sector enters the final stretch of Q2 2026 earnings season. Institutional positioning signals measured optimism, though thin summer liquidity continues to amplify intraday swings. With major MSO reporting dates clustered in late July through early August, Monday’s open sets the tone for what could be the highest-volume catalyst week of the quarter.
Market Analysis
MSOS — the AdvisorShares Pure US Cannabis ETF and the sector’s most closely watched liquidity proxy — enters Monday’s session having posted consecutive weekly gains through July. Friday’s close cemented a pattern of higher lows on the weekly chart, a technical structure that institutional desks tend to read as distribution exhaustion rather than speculative accumulation. Volume profiles over the trailing five sessions remained below the 90-day average, consistent with pre-earnings caution rather than outright distribution.
Individual names are telling a differentiated story. Green Thumb Industries (GTBIF) held its post-earnings range from late June while the broader sector consolidated, suggesting the name has become a relative-strength anchor within the MSO peer group. Curaleaf Holdings (CURLF) and Trulieve Cannabis (TCNNF) have both shown stabilization following the mid-June correction, with each trading above their respective 50-day moving averages heading into Monday’s open. Verano Holdings (VRNOF) has seen tighter spread compression in recent sessions — historically a leading indicator of institutional reengagement ahead of a catalyst.
Canadian licensed producers presented a mixed picture heading into the new week. Tilray Brands (TLRY) continues to trade in a well-defined range as the market awaits firmer international revenue data, while Organigram Holdings (OGI) consolidates following its recent EU-medical expansion update. Canopy Growth (CGC) remains structurally challenged at current price levels but has stabilized, limiting its drag on the broader LP complex.
From a flow perspective, options activity in MSOS showed an uptick in call buying at the 9-strike into Friday’s close — not a high-conviction signal on its own, but worth monitoring alongside open interest accumulation data through the week. Real-money positioning data from weekly 13F updates will offer a clearer read on institutional intent once the reporting cycle completes later in July.
Sector breadth, measured across the 25 largest cannabis names by market cap, remains modestly positive: approximately 16 of 25 names are trading above their 20-day moving averages as of last Friday. That ratio has held in the 60–65% range for three consecutive weeks — a plateau consistent with a market pausing to consolidate gains before the next directional move. Historical precedent across 2024 and 2025 pre-earnings cycles suggests this plateau typically resolves to the upside when earnings guidance comes in line with or above analyst consensus.
Regulatory and Market Context
The regulatory backdrop continues to evolve, albeit slowly. The DEA’s Schedule III reclassification process remains in procedural limbo following the administrative law judge hearing conclusion earlier this year, with the final rule still pending OMB review. Market participants have largely priced in a 12–18 month timeline to implementation, which means Schedule III is no longer acting as a near-term catalyst — but it is functioning as a structural floor under sentiment. Any unexpected acceleration in the procedural timeline would be a sharp positive catalyst; further delays are unlikely to surprise the market meaningfully at this stage.
State-level momentum remains the more immediate market driver. Illinois continues to generate best-in-class revenue metrics for operators with concentrated store footprints, with June monthly sales data expected mid-month. New Jersey’s adult-use market has normalized following last year’s licensing surge, and the state is now demonstrating the steady per-door revenue improvement that signals a maturing high-value market. Michigan and Colorado continue to pressure multi-state operators with aggressive adult-use price compression, though operators with vertically integrated supply chains have shown improving gross margin stability.
Florida remains a critical swing variable for the sector. Amendment 3’s implementation pathway continues to be contested at the state legislative level, and any news on the Florida adult-use timeline — positive or negative — will have outsized impact on CURLF, TCNNF, and Jushi Holdings, all of which carry Florida as a material percentage of current revenue.
Conclusion: Forward-Looking Positioning
The week of July 13 sets up as a positioning week rather than a news-driven week for cannabis equities. With Q2 earnings still 2–3 weeks out for the largest MSOs, the market is in a phase where sector-level momentum and macro risk sentiment will dominate intraday moves more than company-specific catalysts.
Investors with active cannabis allocations should watch MSOS’s ability to hold above last week’s midpoint on any early-week pullback — that level has acted as reliable demand on three prior tests. A break below would not necessarily signal a trend reversal, but would likely invite short-term technical selling that could create better entry levels ahead of earnings.
For real-time price data and cannabis equity tracking across MSOs and LPs, visit the cannabis stock tracker to monitor daily moves across the full sector. The next major test for the sector’s technical structure comes with July monthly sales data from key states, expected in the second and third weeks of the month — watch for those prints to either confirm or challenge the constructive pre-earnings thesis currently embedded in price action.